ReachBio LLC

ReachBio LLC is a life science company that provides specialized contract assay services and cell-based products to organizations worldwide. The company focuses on the use of primary cell systems for high-value applications such as drug discovery, screening, and toxicity testing. ReachBio offers a range of services, including contract assay services, contract research, and educational services, as well as a variety of cell-based products, including pre-qualified human cells and media for cell culture. With a strong emphasis on personalized and collaborative research, ReachBio aims to help its clients develop the best possible drug candidates for treating diseases.

ReachBio LLC provides specialized contract assay services (in vitro and in vivo) and cell-based products to life science organizations worldwide. The company’s focus is on the use of primary cell systems for high value applications such as drug discovery & screening and toxicity testing.
Our focus is in blood and bone marrow, offering a variety of contract services that include hemotoxicity, differential toxicity, multiple species and lineages, cancer stem cell assays, drug efficacy, flow cytometry and customized cell biology. We also offer specialized media for hematopoietic and mesenchymal cell culture. Our cell products include various subsets derived from primary human whole blood, mobilized blood, cord blood and bone marrow.

PRODUCTS
PRE-QUALIFIED HUMAN CELLS
HUMAN HEMATOPOIETIC CELLS
MEDIA FOR CFC ASSAYS
Mesenchymal cell culture media

LABORATORY SERVICES
CONTRACT ASSAY SERVICES
CONTRACT RESEARCH
ASSAY DESIGN & DEVELOPMENT
OPTIONAL ON-SITE SERVICES

EDUCATIONAL SERVICES

CONSULTING

2007